• Conferences

    Jun 28, 2020, 16:41 PM

  • Next Steps in Innovative Pricing Models: Shared Risks, Shared Benefits

    Jun 26, 2020, 16:39 PM

  • By the Numbers

    Jun 26, 2020, 16:39 PM

  • Virtual Research: What It Is and What It’s Doing in the Real-World Setting

    Jun 26, 2020, 16:37 PM

  • New Patient-Derived Outcomes for Coverage Decisions

    Jun 26, 2020, 16:36 PM

  • From the Journals

    Jun 26, 2020, 16:36 PM

  • Choosing the Appropriate Modeling Method for a Given Problem: Health Economic Modeling, Causal Modeling, Simulation, or Constrained Optimization?

    Jun 26, 2020, 16:34 PM

  • Opportunity Offered by a Good Crisis: COVID-19 Impact on Innovative Pricing Models

    Jun 26, 2020, 16:32 PM

  • Research Roundup

    Jun 26, 2020, 16:31 PM

  • HEOR News

    Jun 26, 2020, 16:26 PM

  • ISPOR Speaks

    Jun 26, 2020, 16:23 PM

  • Farewell

    Jun 26, 2020, 16:21 PM

  • COVID-19: A Global Pandemic—Two Global Perspectives

    Apr 15, 2020, 16:20 PM

  • Call in the PROs: Giving Credence to the Patient’s Perspective in Healthcare Decision Making

    Apr 15, 2020, 16:17 PM

  • Estimating Comparative Effectiveness When Patients Are Switching Treatments: A Real-World Challenge

    Apr 15, 2020, 16:16 PM

  • Are Missing Data Properly Accounted for in Health Economics and Outcomes Research?

    Apr 15, 2020, 16:15 PM

  • By the Numbers

    Apr 15, 2020, 16:14 PM

  • Conferences

    Apr 15, 2020, 16:12 PM

  • The State of Health Technology Assessment

    Apr 14, 2020, 10:33 AM

  • The COVID-19 Virus in Wuhan, China: A Personal Story

    Apr 14, 2020, 10:30 AM

  • From the Region

    Apr 14, 2020, 10:28 AM

  • From the Journals

    Apr 14, 2020, 10:27 AM

  • Research Roundup

    Apr 14, 2020, 10:17 AM

  • HEOR News

    Apr 14, 2020, 10:16 AM

  • ISPOR Speaks

    Apr 14, 2020, 10:08 AM

  • From the President

    Apr 14, 2020, 10:06 AM

  • ISPOR in the Time of Corona

    Apr 14, 2020, 10:04 AM

  • Interview With Value & Outcomes Spotlight Editor David Thompson, PhD

    Feb 18, 2020, 13:31 PM

  • Treatment-Line Versus Patient-Level Matching: A Case Study in Oncology

    Feb 18, 2020, 13:30 PM

  • The ABCs of Real Option Value of Medical Technologies

    Feb 18, 2020, 13:29 PM

  • Electronic Recruitment and Validation of Patients for Outcomes Research Studies in Rare Diseases: What Are the Potential Challenges?

    Feb 18, 2020, 13:27 PM

  • By the Numbers: The New Digital Healthcare Ecosystem

    Feb 18, 2020, 13:24 PM

  • The New Digital Health Ecosystem: Looking Outside to Harness Data From Within

    Feb 18, 2020, 13:23 PM

  • News from the Region

    Feb 18, 2020, 13:20 PM

  • Conferences & Education

    Feb 18, 2020, 13:17 PM

  • HEOR News

    Feb 18, 2020, 13:16 PM

  • ISPOR Speaks

    Feb 18, 2020, 13:09 PM

  • Time to Go Virtual in Real-World Research

    Feb 18, 2020, 13:08 PM

  • Moving From Volume to Value: Humana’s Approach to Addressing the Affordability Challenge

    Dec 11, 2019, 12:19 PM

  • Redefining Access to Innovative Oncology Therapies: Can Managed Entry Agreements Help?

    Dec 11, 2019, 12:18 PM

  • Has the Time Come to Replace Randomized Controlled Trials With Real-World Evidence? A Case of Medical Devices

    Dec 11, 2019, 12:16 PM

  • Lies, Damned Lies, and Cost-Effectiveness: Open-Source Models Are Essential if Cost-Effectiveness Analyses Are to Be Widely Accepted

    Dec 11, 2019, 12:13 PM

  • By the Numbers: Balancing Affordability, Value, and Access

    Dec 11, 2019, 12:08 PM

  • The Balance Between Affordability, Value, and Access

    Dec 11, 2019, 12:07 PM

  • Awards

    Dec 11, 2019, 12:06 PM

  • From the Journals

    Dec 11, 2019, 12:05 PM

  • Conferences & Education

    Dec 11, 2019, 12:03 PM

  • HEOR News

    Dec 11, 2019, 12:02 PM

  • Transparency in Real-World Evidence: Trust, but Verify

    Dec 11, 2019, 12:01 PM

  • A Most Difficult Balancing Act

    Dec 11, 2019, 11:58 AM

  • Aging in Asia: A Japanese Perspective, An Interview with Isao Kamae, PhD, MD

    Oct 11, 2019, 16:04 PM

  • A Collaborative Approach to the Intersection of the Real World with the Highest Quality Standards

    Oct 11, 2019, 16:03 PM

  • Novel Value Measures and European HTA: Implications for Pharma/Device HEOR

    Oct 11, 2019, 16:02 PM

  • Drug Disinvestment - Is it Needed and How Could It Work?

    Oct 11, 2019, 16:00 PM

  • Aging Population in Latin America, Healthcare and Pension Systems Challenges: Opportunities for Health Economics and Outcomes Research (HEOR)

    Oct 11, 2019, 15:57 PM

  • Population Aging Conquest or Problem?

    Oct 11, 2019, 15:55 PM

  • Aging of the Global Population: Implications on Healthcare and Provisions of Cost-Effectiveness

    Oct 11, 2019, 15:54 PM

  • By the Numbers: Aging of the Global Population

    Oct 11, 2019, 15:51 PM

  • Anticipating the Impact of an Aging World

    Oct 11, 2019, 15:48 PM

  • Awards

    Oct 11, 2019, 15:46 PM

  • From the Journals

    Oct 11, 2019, 15:45 PM

  • Conferences & Education

    Oct 11, 2019, 15:44 PM

  • HEOR News

    Oct 11, 2019, 15:42 PM

  • ISPOR Conferences: Bringing Us Together to Advance HEOR Around the World

    Oct 11, 2019, 15:39 PM

  • Global Impact of the Aging Population

    Oct 11, 2019, 15:36 PM

  • Board of Directors

    Aug 8, 2019, 14:19 PM

  • Getting “Personal” With Personalized Medicine: An Interview With Kathryn A. Phillips, PhD

    Aug 8, 2019, 11:44 AM

  • The Potential and Pitfalls of Using Multi-criteria Decision Analysis to Support Health Technology Assessment in Europe

    Aug 8, 2019, 11:42 AM

  • Standardization of Model Validation in Reimbursement Dossiers and Research Dissemination

    Aug 8, 2019, 11:41 AM

  • Digital Health versus Patient Privacy (General Data Protection Regulation): Is the Future Here to Stay?

    Aug 8, 2019, 11:39 AM

  • Insights on How an Experienced CCO Delivers Novel Ideas to the World of Genomics: An Interview with Joanne M. Hackett

    Aug 8, 2019, 11:35 AM

  • By the Numbers: Personalized Medicine Based on Whole Genome Sequencing

    Aug 8, 2019, 11:33 AM

  • A Review of Precision Medicine, Companion Diagnostics, and the Challenges Surrounding Targeted Therapy

    Aug 8, 2019, 11:30 AM

  • From the Journals

    Aug 8, 2019, 11:24 AM

  • Conferences & Education

    Aug 8, 2019, 11:23 AM

  • HEOR News

    Aug 8, 2019, 11:21 AM

  • ISPOR Speaks: Important Opportunities and Challenges

    Aug 8, 2019, 09:54 AM

  • Precision Medicine: The Artist Formerly Known as Personalized Medicine

    Aug 8, 2019, 09:51 AM

  • Extreme Remedies: Thoughts on the Future of Curative Therapies With Don Husereau, BScPharm and Shelby Reed, RPh, PhD

    May 8, 2019, 11:51 AM

  • Estimating the Costs of Adverse Events in Economic Models: Is There a “Right” Approach?

    May 8, 2019, 11:50 AM

  • An Algorithmic Approach to Optimal Study Design for HEOR and Real-World Evidence

    May 8, 2019, 11:48 AM

  • The Value of Transformative Therapies: An Interview with Bill Guyer

    May 8, 2019, 11:47 AM

  • Measuring Value in Healthcare Beyond Cost

    May 8, 2019, 11:45 AM

  • By the Numbers: By the Numbers: Curative Therapies

    May 8, 2019, 11:43 AM

  • Health Technology Assessment of Curative Interventions—an Old Problem With New Issues

    May 8, 2019, 11:41 AM

  • From the Journals

    May 8, 2019, 11:38 AM

  • Conferences & Education

    May 8, 2019, 11:36 AM

  • HEOR News

    May 8, 2019, 11:29 AM

  • ISPOR Speaks

    May 8, 2019, 11:23 AM

  • Curative Therapies Have Rocked Our World

    May 8, 2019, 11:17 AM

  • Artificial Intelligence in Health—An Interview with Eric Topol, MD

    Apr 12, 2019, 09:20 AM

  • Truly, Broadly, and Deeply: How Dynamic Visualizations Are Changing the Way We Understand and Communicate HEOR Findings

    Apr 12, 2019, 09:10 AM

  • A Health Economist Walks Into a Tech Company: Principles for Reproducible Real-World Analyses

    Apr 12, 2019, 08:57 AM

  • By the Numbers: Artificial Intelligence in Health—Trial and Tribulations

    Apr 11, 2019, 16:33 PM

  • Is Artificial Intelligence the Next Big Thing in Health Economics and Outcomes Research?

    Apr 11, 2019, 16:22 PM

  • Artificial Intelligence: The Key to Unlocking Novel Real-World Data?

    Apr 11, 2019, 16:18 PM

  • From the Journals

    Apr 11, 2019, 16:12 PM

  • Conferences & Education

    Apr 11, 2019, 16:08 PM

  • HEOR News

    Apr 11, 2019, 16:06 PM

  • ISPOR Speaks - Getting the Right Science

    Apr 11, 2019, 15:58 PM

  • The Artificial Intelligence Issue

    Apr 11, 2019, 15:43 PM

  • The Opioid Crisis: An Interview With Douglas C. Throckmorton, MD

    Feb 22, 2019, 14:20 PM

  • Furthering Patient Engagement in Health Economics and Outcomes Research: Exploratory Research by ISPOR and the National Health Council

    Feb 22, 2019, 14:14 PM

  • Medical Device Real-World Evidence for Beginners: A Primer

    Feb 22, 2019, 14:07 PM

  • Network Meta-Analysis for Various Study Designs: Stepping Outside the Randomized Controlled Trials Comfort Zone Into the Real World

    Feb 22, 2019, 14:04 PM

  • Is Pharmacotherapy Enough to Manage the Opioid Crisis?

    Feb 22, 2019, 13:53 PM

  • By the Numbers - The Global Opioid Crisis

    Feb 22, 2019, 13:51 PM

  • The Current State of the Global Opioid Crisis

    Feb 22, 2019, 13:49 PM

  • From the Journals

    Feb 22, 2019, 13:47 PM

  • Conferences & Education

    Feb 22, 2019, 13:41 PM

  • HEOR News

    Feb 22, 2019, 13:37 PM

  • ISPOR Speaks - Milestones of the Past and a Path for the Future

    Feb 22, 2019, 13:33 PM

  • Starting 2019 With a Bang!

    Feb 22, 2019, 13:21 PM

  • The “Patient Journey” to Real-World Evidence: An Interview With Tanisha Carino

    Jan 9, 2019, 15:55 PM

  • By the Numbers: Policy Changes from the 21st Century Cures Act

    Jan 9, 2019, 15:46 PM

  • Regulatory Agencies Act to Bridge the Evidentiary Gap: Might This Lead to an Expanded Role for Pragmatic Trials?

    Jan 9, 2019, 15:40 PM

  • From the Journals - Value in Health and Value in Health Regional Issues

    Jan 9, 2019, 15:17 PM

  • From the Journals - A Year of Growth and Expansion: Value in Health in Review

    Jan 9, 2019, 15:12 PM

  • Measuring Value and Its Impact on Pricing and Coverage Decisions: ISPOR Summit 2018

    Jan 9, 2019, 15:06 PM

  • ISPOR Conferences: Contribute to Advance the Science!

    Jan 9, 2019, 15:03 PM

  • The Role of Real-World Data in Clinical Development

    Jan 9, 2019, 14:50 PM

  • Let There Be Light: Improving Transparency in the Biopharmaceutical Supply Chain

    Jan 9, 2019, 14:41 PM

  • Recent Initiatives in US Drug Policy to Promote Innovation, Value, Access, and Affordability

    Jan 9, 2019, 14:34 PM

  • HEOR News

    Jan 9, 2019, 14:26 PM

  • ISPOR Awards - Call for Nominations

    Jan 9, 2019, 14:24 PM

  • ISPOR Awards - New ISPOR Program Recognizes Outstanding Contribution of Regional Chapters: Spotlight on Russia St. Petersburg, Mexico, and Colombia Chapters

    Jan 9, 2019, 14:20 PM

  • ISPOR Awards - A Career Intertwined with ISPOR Leadership: Finn Børlum Kristensen

    Jan 9, 2019, 14:17 PM

  • In Memoriam - A Tribute to ISPOR Founding Executive Director Marilyn Dix Smith, RPh, PhD

    Jan 9, 2019, 13:56 PM

  • ISPOR Speaks - Collaboration to Advance the Science: ISPOR’s Institutional Council

    Jan 9, 2019, 13:54 PM

  • FDA Releases Framework for RWE Program

    Jan 9, 2019, 13:47 PM

  • Impact of mHealth on Real-World Research

    Oct 13, 2018, 16:56 PM

  • ISPOR Scientific Achievement Awards

    Oct 13, 2018, 16:46 PM

  • Call for Papers

    Oct 13, 2018, 16:41 PM

  • Blockchain and Electronic Medical Records: An Interview With Renata Nunes Aranha and Leticia Lazaridis Goldberg

    Oct 13, 2018, 13:48 PM

  • How Health State Utilities Used in Cost-Effectiveness Models Are Currently Identified, Reviewed, and Reported

    Oct 13, 2018, 13:47 PM

  • Estimands—What Do They Mean for Health Technology Assessment?

    Oct 13, 2018, 13:46 PM

  • Oncology Value Framework in the Era of Digital Health Technology: A Patient-Centric Approach

    Oct 13, 2018, 13:42 PM

  • By the Numbers: eHealth/Digital Health

    Oct 13, 2018, 13:41 PM

  • How mHealth Technology is Revolutionizing Clinical Research

    Oct 13, 2018, 13:41 PM

  • From the Journals

    Oct 13, 2018, 13:41 PM

  • Conferences & Events

    Oct 13, 2018, 13:40 PM

  • Research Roundup

    Oct 13, 2018, 13:40 PM

  • HEOR News

    Oct 13, 2018, 13:39 PM

  • ISPOR Awards

    Oct 13, 2018, 13:38 PM

  • ISPOR Speaks - Investments in Technology to Improve Services to our Members

    Oct 13, 2018, 13:25 PM

  • 2018-2019 Board of Directors Take Office

    Aug 9, 2018, 14:26 PM

  • Research Roundup

    Aug 9, 2018, 14:24 PM

  • Real-World Evidence and Health Technology Assessment: An Interview With Dennis Raisch, PhD

    Aug 9, 2018, 14:22 PM

  • ISPOR Speaks – Snapshots of the Past, Present, and Future: Shaping ISPOR’s Role on the World Stage

    Aug 9, 2018, 14:19 PM

  • HEOR News

    Aug 9, 2018, 14:17 PM

  • Understanding Productivity Benefits and Related Future Research Needs in Cost-Effectiveness Analysis

    Aug 9, 2018, 14:15 PM

  • Predicting Market Outlook: Enhancing Market Forecasting via Application of Pharmacoeconomic Modeling Techniques

    Aug 9, 2018, 13:55 PM

  • Enhancing Biosimilar Adoption Among Healthcare Providers With Real-World Evidence

    Aug 9, 2018, 13:51 PM

  • Challenges and Best Practices for the Japan Health Technology Assessment Pilot Program

    Aug 9, 2018, 13:38 PM

  • Biosimilar Adoption and Acceptance in Ireland—Still More to Be Done

    Aug 9, 2018, 13:32 PM

  • From the Journals

    Aug 9, 2018, 13:27 PM

  • Biosimilar Acceptance: Can Post-Market Research Change Roadblocks to Runways?

    Aug 9, 2018, 13:22 PM

  • Conferences & Events

    Aug 9, 2018, 13:19 PM

  • By the Numbers

    Aug 9, 2018, 13:17 PM

  • Challenges & Opportunities in Biosimilars

    Aug 8, 2018, 18:02 PM

  • Multiple Criteria Decision Analysis for Health Care Decision Making: An Interview with Kevin Marsh, PhD

    Jul 6, 2018, 15:35 PM

  • Ready for Risk Sharing? Challenges and Implications for Manufacturers

    Jul 6, 2018, 15:32 PM

  • How Do U.S. Payers Use Economic Models Submitted by Life Sciences Organizations?

    Jul 6, 2018, 15:32 PM

  • Time-Dependent Confounders: Are They All the Same?

    Jul 6, 2018, 15:27 PM

  • A Real-World Research Perspective for Biosimilars

    Jul 6, 2018, 15:27 PM

  • Horizon Scanning: Identifying and Estimating Future Impact of Emerging Innovations on US Health Care

    Jul 6, 2018, 15:26 PM

  • Another Remarkable Year for ISPOR

    Jul 6, 2018, 15:26 PM

  • "All In" on ISPOR’s Regional & Student Chapters . . .

    Jul 6, 2018, 15:25 PM

  • The Year of the Patient?

    Jun 30, 2018, 13:46 PM

  • ISPOR Speaks – A Year of Transformation: ISPOR’s Continued Growth and Development

    Jun 29, 2018, 13:54 PM

  • By the Numbers

    Jun 28, 2018, 13:54 PM

  • HEOR News

    Jun 27, 2018, 13:55 PM

  • Research Roundup

    Jun 26, 2018, 13:55 PM

  • Conferences & Education

    Jun 25, 2018, 14:16 PM

  • The Why, Where, Who, How, and What of the Patient Voice in R&D

    Jun 23, 2018, 15:13 PM

  • From the Journals

    Jun 23, 2018, 15:06 PM

  • Donec mattis massa justo, ac condimentum neque efficitur non

    Jun 22, 2018, 17:17 PM

  • Neque porro quisquam est qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit

    Jun 22, 2018, 16:50 PM

  • Giving Patients’ Preferences a Voice in the Medical Product Life Cycle: Why, When, and How?

    Jun 22, 2018, 15:14 PM

  • Defining and Measuring Meaningful Patient Engagement: A Multistakeholder Perspective

    Jun 21, 2018, 15:15 PM

  • Decision Making Across the Healthcare Continuum—The Path Forward Is Patient-Powered

    Jun 20, 2018, 15:16 PM

  • The Patients’ Voice in the Evaluation of Orphan Drugs

    Jun 19, 2018, 15:17 PM

  • Why Does the European Commission Prefer to Sponsor Agriculture Production Than Support Patients’ Access to Orphan Drugs?

    Jun 18, 2018, 15:18 PM

  • Rare Diseases and the Patient: An Interview with Clark Paramore and Jennifer Helfer

    Jun 17, 2018, 15:19 PM

  • Research Roundup

    Apr 24, 2018, 13:46 PM

  • HEOR News

    Apr 24, 2018, 11:21 AM

  • ISPOR Speaks – ISPOR: Extended Excellence

    Apr 24, 2018, 10:31 AM

  • HTA Challenges for Medical Devices

    Apr 24, 2018, 10:23 AM

  • Stochastic Modeling in Health Economics and Outcomes Research: Common Mistakes and How to Avoid Them

    Apr 5, 2018, 13:36 PM

  • Real-World Evidence and Health Technology Assessment: An Interview with Lou Garrison, PhD

    Apr 5, 2018, 13:36 PM

  • How Market Access Works for Medical Devices Is Different from Pharmaceuticals

    Apr 5, 2018, 13:35 PM

  • Potential Utility of Idiographic Clinical Trials in Drug Development

    Apr 5, 2018, 13:35 PM

  • By the Numbers

    Apr 5, 2018, 13:33 PM

  • Health Technology Assessment for Medical Devices Continues to Be a Struggle

    Apr 5, 2018, 13:32 PM

  • From the Journals

    Apr 5, 2018, 13:31 PM

  • Conferences & Events

    Apr 5, 2018, 13:30 PM

  • Developing and Paying for Gene Therapies—Can We Resolve the Conflicts?

    Feb 5, 2018, 15:34 PM

  • Discrete Choice Experiment Methods: An Interview with F. Reed Johnson, PhD

    Feb 5, 2018, 15:34 PM

  • Estimating the Long-Term Outcomes Associated With Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations

    Feb 5, 2018, 15:33 PM

  • Special Considerations for the Analysis of Patient-Level Immuno-Oncology Data

    Feb 5, 2018, 15:32 PM
  • 1 (current)
  • 2
  • 3